China · Delayed Price · Currency is CNY Dalian BIO-CHEM Company Statistics
Total Valuation
SHA:603360 has a market cap or net worth of CNY 6.97 billion. The enterprise value is 8.04 billion.
| Market Cap | 6.97B |
| Enterprise Value | 8.04B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:603360 has 689.28 million shares outstanding. The number of shares has increased by 15.07% in one year.
| Current Share Class | 689.28M |
| Shares Outstanding | 689.28M |
| Shares Change (YoY) | +15.07% |
| Shares Change (QoQ) | -20.85% |
| Owned by Insiders (%) | 31.37% |
| Owned by Institutions (%) | 3.76% |
| Float | 285.14M |
Valuation Ratios
The trailing PE ratio is 49.16.
| PE Ratio | 49.16 |
| Forward PE | n/a |
| PS Ratio | 5.03 |
| PB Ratio | 3.54 |
| P/TBV Ratio | 6.87 |
| P/FCF Ratio | 43.12 |
| P/OCF Ratio | 25.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.11, with an EV/FCF ratio of 49.54.
| EV / Earnings | 54.68 |
| EV / Sales | 5.77 |
| EV / EBITDA | 24.11 |
| EV / EBIT | 36.53 |
| EV / FCF | 49.54 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.70 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.87 |
| Debt / FCF | 7.95 |
| Interest Coverage | 26.10 |
Financial Efficiency
Return on equity (ROE) is 10.36% and return on invested capital (ROIC) is 9.31%.
| Return on Equity (ROE) | 10.36% |
| Return on Assets (ROA) | 3.78% |
| Return on Invested Capital (ROIC) | 9.31% |
| Return on Capital Employed (ROCE) | 7.77% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | 1.36M |
| Profits Per Employee | 144,150 |
| Employee Count | 1,053 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.79 |
Taxes
| Income Tax | -13.80M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.46% in the last 52 weeks. The beta is 0.28, so SHA:603360's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -67.46% |
| 50-Day Moving Average | 12.03 |
| 200-Day Moving Average | 19.91 |
| Relative Strength Index (RSI) | 38.27 |
| Average Volume (20 Days) | 12,354,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603360 had revenue of CNY 1.44 billion and earned 151.79 million in profits. Earnings per share was 0.21.
| Revenue | 1.44B |
| Gross Profit | 507.44M |
| Operating Income | 227.22M |
| Pretax Income | 199.64M |
| Net Income | 151.79M |
| EBITDA | 338.15M |
| EBIT | 227.22M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 903.16 million in cash and 1.33 billion in debt, with a net cash position of -429.49 million or -0.62 per share.
| Cash & Cash Equivalents | 903.16M |
| Total Debt | 1.33B |
| Net Cash | -429.49M |
| Net Cash Per Share | -0.62 |
| Equity (Book Value) | 2.04B |
| Book Value Per Share | 2.29 |
| Working Capital | 1.60B |
Cash Flow
In the last 12 months, operating cash flow was 285.90 million and capital expenditures -118.37 million, giving a free cash flow of 167.53 million.
| Operating Cash Flow | 285.90M |
| Capital Expenditures | -118.37M |
| Depreciation & Amortization | 110.93M |
| Net Borrowing | 151.79M |
| Free Cash Flow | 167.53M |
| FCF Per Share | 0.24 |
Margins
Gross margin is 35.30%, with operating and profit margins of 15.81% and 10.56%.
| Gross Margin | 35.30% |
| Operating Margin | 15.81% |
| Pretax Margin | 13.89% |
| Profit Margin | 10.56% |
| EBITDA Margin | 23.53% |
| EBIT Margin | 15.81% |
| FCF Margin | 11.66% |
Dividends & Yields
SHA:603360 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 22.40% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -15.07% |
| Shareholder Yield | -15.07% |
| Earnings Yield | 2.03% |
| FCF Yield | 2.32% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 29, 2025. It was a forward split with a ratio of 1.4.
| Last Split Date | May 29, 2025 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |